CAPSTONE INVESTMENT ADVISORS, LLC - BRIDGEBIO PHARMA INC ownership

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$1,500,000
+21.2%
2,000,0000.0%0.01%
+16.7%
Q2 2023$1,237,754
-4.4%
2,000,0000.0%0.01%
-14.3%
Q1 2023$1,294,703
+69.5%
2,000,0000.0%0.01%
+16.7%
Q4 2022$763,7502,000,0000.01%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Diameter Capital Partners LP 71,757,000$44,221,6864.15%
Context Capital Management, LLC 33,683$20,8461.88%
INHERENT GROUP, LP 9,000,000$5,587,1731.54%
BRAIDWELL LP 62,294,000$38,552,3281.26%
Aequim Alternative Investments LP 30,000,000$18,566,3120.70%
DeepCurrents Investment Group LLC 22,355,000$13,838,3720.55%
ABSOLUTE INVESTMENT ADVISERS, LLC 5,500,000$3,408,5920.48%
ARISTEIA CAPITAL, L.L.C. 30,280,000$18,739,5980.42%
Weiss Asset Management LP 4,500,000$2,773,2090.21%
Orbimed Advisors 15,000,000$9,265,3500.17%
View complete list of BRIDGEBIO PHARMA INC shareholders